TC BioPharm Company
TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.
Technology:
AgeTech Companies, CAR-T therapy
Industry:
Covid-19, Public
Headquarters:
Holytown, North Lanarkshire, United Kingdom
Founded Date:
2013-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
8
Total Funding:
52880825
Estimated Revenue:
$1M to $10M
Last Funding Date:
2023-03-28
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership